InvestorsHub Logo
Followers 4
Posts 309
Boards Moderated 0
Alias Born 07/09/2018

Re: Regis999 post# 9279

Thursday, 06/27/2019 10:01:08 AM

Thursday, June 27, 2019 10:01:08 AM

Post# of 10346
One should beware of a scenario in which a company registers the same patent in a large number of countries and declares a large number of patents. Also, the December 2018 510(k) has led to what? 3-D Matrix has launched a hemostat for use in GI endoscopy in Europe. Question is: not about differences in commercial product (ARTH has none at this time), but what are differences in technology? Is there a significant, useful differentiation? If so, what is it?